Severe acute respiratory syndrome (original) (raw)

• Smith, M.D. Plague. in Manson's Tropical Diseases 21st edn (eds Cook, G.C. & Zumla, A.) Ch. 63, 1125–1131 (W. B. Saunders, London, 2003).
  Google Scholar
• Shortridge, K.F. & Stuart-Harris, C.H. An influenza epicentre? Lancet 2, 812–813 (1982).
  Article CAS PubMed Google Scholar
• Centers for Disease Control and Prevention. Update: outbreak of severe acute respiratory syndrome—worldwide, 2003. Morbid. Mortal. Wkly. Rpt. 52, 241–248 (2003).
• Tsang, K.W. et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1977–1985 (2003).
  Article PubMed Google Scholar
• Lee, N. et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1986–1994 (2003).
  Article PubMed Google Scholar
• Poutanen, S.M. et al. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348, 1995–2005 (2003).
  Article PubMed Google Scholar
• Peiris, J.S. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325 (2003).
  Article CAS PubMed Google Scholar
• Ksiazek, T.G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953–1966 (2003).
  Article CAS PubMed Google Scholar
• Drosten, C. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967–1976 (2003).
  Article CAS PubMed Google Scholar
• Poon, L.L. et al. Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin. Chem. 49, 953–955 (2003).
  Article CAS PubMed Google Scholar
• Marra, M.A. et al. The genome sequence of the SARS associated coronavirus. Science 300, 1399–1404 (2003).
  Article CAS PubMed Google Scholar
• Rota, P.A. et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394–1399 (2003).
  Article CAS PubMed Google Scholar
• Enserink, M. One year after outbreak. SARS virus yields some secrets. Science 304, 1097 (2004).
  Article CAS PubMed Google Scholar
• Peiris, J.S.M., Yuen, K.Y., Osterhaus, A.D.M.E. & Stohr, K. The severe acute respiratory syndrome. N. Engl. J. Med. 349, 2431–2441 (2003).
  Article CAS PubMed Google Scholar
• Christian, M.D., Poutanen, S.M., Loufty, M.R., Muller, M.P. & Low, D.E. Severe acute respiratory syndrome. Clin. Infect. Dis. 38, 1420–1427 (2004).
  Article PubMed Google Scholar
• Rainer, T.H. Severe acute respiratory syndrome: clinical features, diagnosis and management. Curr. Opin. Pulm. Med. 10, 159–165 (2004).
  Article PubMed Google Scholar
• Drosten, C., Preiser, W., Gunther, S., Schmitz, H. & Doerr, H.W. Severe acute respiratory syndrome: identification of the aetiologic agent. Trends Mol. Med. 9, 325–327 (2003).
  Article PubMed Google Scholar
• Holmes, K.V. SARS coronavirus: a new challenge for prevention and therapy. J. Clin. Invest. 111, 1605–1609 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Davidson, A. & Siddell, S. Potential for antiviral treatment of severe acute respiratory syndrome. Curr. Opin. Infect. Dis. 26, 565–571 (2003).
  Article Google Scholar
• Stadler, K. et al. SARS—beginning to understand a new virus. Nat. Rev. Microbiol. 1, 209–218 (2003).
  Article CAS PubMed Google Scholar
• Poon, L.L.M., Guan, Y., Nicholls, N.J., Yuen, K.Y. & Peiris, J.S.M. The aetiology, origins and diagnosis of SARS. Lancet Infect. Dis. 4, 663–671 (2004).
  Article CAS PubMed Google Scholar
• Anderson, R.M. et al. Epidemiology, transmission dynamics, and control of SARS. The 2002–2003 epidemic. Phil. Trans. R. Soc. Lond. B 359, 1091–1105 (2004).
  Article Google Scholar
• Poutanen, S.M. & Low, D.E. Severe acute respiratory syndrome: an update. Curr. Opin. Infect. Dis. 17, 287–294 (2004)
  Article PubMed Google Scholar
• Poutanen, S.M. & McGeer, A.J. Transmission and control of severe acute respiratory syndrome. Curr. Infect. Dis. Rep. 6, 220–227 (2004)
  Article PubMed Google Scholar
• Weinstein, R.A. Planning for epidemics—the lessons of SARS. N. Engl. J. Med. 350, 2332–2334 (2004).
  Article CAS PubMed Google Scholar
• Zhong, N.S. et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February 2003. Lancet 362, 1355–1358 (2003).
  Article Google Scholar
• Xu, R.H. et al. Epidemiologic clues to SARS origin in China. Emerg. Infect. Dis. 10, 1030–1037 (2004).
  Article PubMed PubMed Central Google Scholar
• Zhong, N.S. & Zeng, G.Q. Our strategies for fighting severe acute respiratory syndrome (SARS). Am. J. Respir. Crit. Care Med. 168, 7–9 (2003).
  Article PubMed Google Scholar
• Guan, Y. et al. Isolation and characterization of viruses related to SARS coronavirus from animals in southern China. Science 302, 276–278 (2003).
  Article CAS PubMed Google Scholar
• Centers for Disease Control and Prevention. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders—Guangdong Province, China, 2003. Morb. Mortal. Wkly. Rep. 52, 986–987 (2003).
• Klempner, M.S. & Shapiro, D.S. Crossing the species barrier—one small step to man, one giant leap to mankind. N. Engl. J. Med. 350, 1171–1172 (2004).
  Article CAS PubMed Google Scholar
• Snijder, E.J. et al. Unique and conserved features of genomes and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 33, 991–1004 (2003).
  Article CAS Google Scholar
• Gorbalenya, A.E., Snijder, A.E. & Spaan, W.J. Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J. Virol. 78, 7863–7866 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• The Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303, 1666–1669 (2004).
• Guan, Y. et al. Molecular epidemiology of SARS coronavirus in Hong Kong. Lancet 363, 99–104 (2004).
  Article CAS PubMed Google Scholar
• Ruan, Y. et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361, 1779–1785 (2003).
  Article CAS PubMed Google Scholar
• Yeh, S.H. et al. Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc. Natl. Acad. Sci. USA 101, 2542–2547 (2004).
  Article CAS PubMed Google Scholar
• Zhong, N. Management and prevention of SARS in China. Phil. Trans. R. Soc. Lond. B. 359, 1115–1116 (2004).
  Article Google Scholar
• Liang, G. et al. Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg. Infect. Dis. 10, 1774–1781 (2004).
  Article PubMed PubMed Central Google Scholar
• Wong, T.W. et al. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg. Infect. Dis. 10, 269–276 (2004).
  Article PubMed PubMed Central Google Scholar
• Seto, W.H., et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 361, 1519–1520 (2003).
  Article CAS PubMed Google Scholar
• Loon, S.C. et al. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 88, 861–863 (2004).
  Article PubMed PubMed Central Google Scholar
• Leung, G.M. et al. SARS CoV antibody prevalence in all Hong Kong patient contacts. Emerg. Infect. Dis. 10, 1653–1656 (2004)
  Article PubMed PubMed Central Google Scholar
• Lipsitch, M. et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 300, 1966–1970 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Goh, D.L.M. et al. Secondary household transmission of SARS, Singapore. Emerg. Infect. Dis. 10, 232–234 (2004).
  Article PubMed PubMed Central Google Scholar
• Shen, Z. et al. Super-spreading SARS events in Beijing, 2003. Emerg. Infect. Dis. 10, 256–260 (2004).
  Article PubMed PubMed Central Google Scholar
• Peiris, J.S. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767–1772 (2003).
  Article CAS PubMed Google Scholar
• Chan, K.H. et al. Detection of SARS coronavirus (SCoV) by RT-PCR, culture, and serology in patients with acute respiratory syndrome (SARS). Emerg. Infect. Dis. 10, 294–299 (2004).
  Article PubMed PubMed Central Google Scholar
• Chan, P.K. et al. Laboratory diagnosis of SARS. Emerg. Infect. Dis. 10, 825–830 (2004).
  Article PubMed PubMed Central Google Scholar
• Li, L. et al. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J. Clin. Virol. 28, 239–244 (2003).
  Article CAS PubMed Google Scholar
• Ng, E.K. et al. Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. Clin. Chem. 49, 2085–2088 (2003).
  Article CAS PubMed Google Scholar
• Wong, R.S.M. et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 326, 1358–1362 (2003).
  Article PubMed PubMed Central Google Scholar
• Li, T. et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J. Infect. Dis. 189, 648–651 (2004).
  Article PubMed Google Scholar
• Leung, C.W. et al. Severe acute respiratory syndrome in children. Pediatrics 113, e535–e543 (2004).
  Article PubMed Google Scholar
• Hon, K.L. et al. Clinical presentation and outcome of severe acute respiratory syndrome in children. Lancet 361, 1701–1703 (2003).
  Article CAS PubMed Google Scholar
• Drosten, C. et al. Evaluation of advanced reverse transcription PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J. Clin. Microbiol. 42, 2043–2047 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Cheng, P.K.C. et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 363, 1699–1700 (2004).
  Article PubMed Google Scholar
• Kaiser, L., Briones, M.S. & Hayden, F.G. Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection. J. Clin. Virol. 14, 191–197 (1999).
  Article CAS PubMed Google Scholar
• Ng, E.K. et al. Quantitation analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin. Chem. 49, 1976–1980 (2003).
  Article CAS PubMed Google Scholar
• Hung, I.F. et al. Viral loads in clinical specimens and SARS manifestations. Emerg. Infect. Dis. 10, 1550–1557 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Chu, C.M. et al. The role of lopinavir/ritonavir in treatment of SARS: initial virological and clinical findings. Thorax 59, 252–256 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Mazzulli, T. et al. Severe acute respiratory syndrome–associated coronavirus in lung tissue. Emerg. Infect. Dis. 10, 20–24 (2003).
  Article Google Scholar
• Nicholls, J.M. et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361, 1773–1778 (2003).
  Article PubMed Google Scholar
• Franks, T.J. et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 34, 743–748 (2003).
  Article PubMed Google Scholar
• Chow, K.C. et al. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am. J. Clin. Pathol. 121, 574–580 (2004).
  Article CAS PubMed Google Scholar
• To, K.F. et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in situ hybridization study of fatal cases. J. Pathol. 202, 157–163 (2004).
  Article CAS PubMed Google Scholar
• Nakajima, N. et al. SARS Coronavirus-infected cells in lung detected by new in situ hybridization technique. Jpn. J. Infect. Dis. 56, 139–141 (2003).
  PubMed Google Scholar
• Chong, P.Y. et al. Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore. Arch. Pathol. Lab. Med. 128, 195–204 (2004).
  PubMed Google Scholar
• Ding, Y. et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203, 622–630 (2004).
  Article CAS PubMed Google Scholar
• To, K.F. & Lo, A.W.I. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS CoV) and its putative receptor, angiotensin-converting-enzyme 2 (ACE-2). J. Pathol. 203, 740–743 (2004).
  Article CAS PubMed Google Scholar
• Leung, W.K. et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 125, 1011–1017 (2003).
  Article PubMed Google Scholar
• Chan, P.K.S. et al. Persistent infection of SARS coronavirus in colonic cells in vitro. J. Med. Virol. 74, 1–7 (2004).
  Article PubMed Google Scholar
• Cinatl, J. et al. Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus. Cell Mol. Life Sci. 61, 2100–2112 (2004).
  Article CAS PubMed Google Scholar
• Yang, Z.Y. et al. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC SIGN. J. Virol. 78, 5642–5650 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Simmons, G. et al. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA 101, 4240–4245 (2004).
  Article CAS PubMed Google Scholar
• Hoffmann, H. et al. Susceptibility to SARS coronavirus S protein-derived infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem. Biophys. Res. Comm. 319, 1216–1221 (2004).
  Article CAS Google Scholar
• Han, D.P., Kim, H.G., Kim, Y.B., Poon, L.L.M. & Cho, M.W. Development of a safe neutralization assay for SARS CoV and characterization of S-glycoprotein. Virology 326, 140–149 (2004).
  Article CAS PubMed Google Scholar
• Bosch, B.J. et al. Severe acute respiratory syndrome associated coronavirus (SARS CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. USA 101, 8455–8460 (2004).
  Article CAS PubMed Google Scholar
• Liu, S. et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechnism and identification of fusion inhibitors. Lancet 363, 938–947 (2004).
  Article CAS PubMed Google Scholar
• Qinfen, Z., et al. The life cycle of SARS coronavirus in Vero E6 cells. J. Med. Virol. 73, 332–337 (2004).
  Article PubMed CAS Google Scholar
• Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454 (2003).
  Article CAS PubMed Google Scholar
• Wang, P. et al. Expression cloning of functional receptor used by SARS coronavirus. Biochem. Biophys. Res. Commun. 315, 439–444 (2004).
  Article CAS PubMed Google Scholar
• Babcock, G.J., Esshaki, D.J., Thomas, W.D. & Ambrosino, D.M. Amino acids 270 to 510 of the severe acute respiratory syndrome spike protein are required for interaction with receptor. J. Virol. 78, 4552–4560 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lai, M.M.C. & Holmes, K.V. Coronaviridae and their replication. in Fields' Virology Vol 2. (eds Knipe, D.M. & Howley, P.M) Ch. 35, 1163–1185 (Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, 2001).
  Google Scholar
• Hammling, I. et al. Tissue distribution of ACE-2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631–637 (2004).
  Article CAS Google Scholar
• Yount, B. et al. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 100, 12995–13000 (2003).
  Article CAS PubMed Google Scholar
• Wong, C.K. et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 136, 95–103 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Y. et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect. Immun. 72, 4410–4415 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ng, P.C. et al. Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics 113, e7–e14 (2004).
  Article PubMed Google Scholar
• Lee, C.H. et al. Altered p38 mitogen-activated protein kinase expression in different leukocytes with increment of immunosuppressive mediators in patients with severe acute respiratory syndrome. J. Immunol. 172, 7841–7847 (2004).
  Article CAS PubMed Google Scholar
• Peiris, J.S.M. et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617–619 (2004).
  Article CAS PubMed Google Scholar
• Jones, B.M. et al. Prolonged disturbance of in vitro cytokine production inpatients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clin. Exp. Immunol. 135, 467–473 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Openshaw, P.J.M. What does the peripheral blood tell you in SARS? Clin. Exp. Immunol. 136, 11–12 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, M. et al. Association of HLA class 1 with severe acute respiratory syndrome coronavirus infection. BMC Med. Genet. 4, 9 (2003).
  Article PubMed PubMed Central Google Scholar
• Ng, M.H.L. et al. Association of human-leukocyte-antigen class 1 (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J. Infect. Dis. 190, 5151–5158 (2004).
  Article Google Scholar
• Fouchier, R.A.M. et al. Koch's postulates fulfilled for SARS virus. Nature 423, 240 (2003).
  Article CAS PubMed Google Scholar
• Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263–270 (2003).
  Article CAS PubMed Google Scholar
• Rowe, T. et al. Macaque model for severe acute respiratory syndrome. J. Virol. 78, 11410–11414 (2004).
  Article CAS Google Scholar
• Martina, B.E. et al. Virology: SARS virus infection of cats and ferrets. Nature 425, 915 (2003).
  Article CAS PubMed Google Scholar
• Bukreyev, A. et al. Mucosal immunisation of African green monkeys (Cercopithicus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 363, 2122–2127 (2004).
  Article CAS PubMed Google Scholar
• Subbarao, K. et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78, 3572–3577 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Buchholtz, U.J. et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc. Natl. Acad. Sci. USA 101, 9804–9809 (2004).
  Article Google Scholar
• Roberts, A. et al. SARS coronavirus infection in Golden Syrian hamsters. J. Virol. (in the press).
• Wu, C.Y. et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. USA 101, 10012–10017 (2004).
  Article CAS PubMed Google Scholar
• Wu, C.J. et al. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrob. Agents Chemother. 48, 2693–2696 (2004)
  Article CAS PubMed PubMed Central Google Scholar
• Chen, F. et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 31, 69–75 (2004).
  Article PubMed CAS Google Scholar
• Yi, Y. et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 78, 11334–11339 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Yamamoto, N. et al. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem. Biophys. Res. Commun. 318, 719–725 (2004).
  Article CAS PubMed Google Scholar
• Tan, E.L. et al. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg. Infect. Dis. 10, 581–586 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hensley, L.E. et al. Interferon-β 1a and SARS coronavirus replication. Emerg. Infect. Dis. 10, 317–319 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Stroher, U. et al. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-α. J. Infect. Dis. 189, 1164–1167 (2004).
  Article PubMed Google Scholar
• Spiegel, M., Pichlmair, A., Muhlberger, E., Haller, O. & Weber, F. The antiviral effect of interferon-β against SARS coronavirus is not mediated by MxA protein. J. Clin. Virol. 30, 211–213 (2004).
  Article CAS PubMed Google Scholar
• Zhang, X.W. & Yap, Y.L. Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic, and parasitic drugs. Bioorg. Med. Chem. 12, 2517–2521 (2004).
  Article CAS PubMed Google Scholar
• Haagmans, B.L. et al. Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10, 290–293 (2004).
  Article CAS PubMed Google Scholar
• Loutfy, M.R. et al. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. J. Am. Med. Assoc. 290, 3222–3228 (2003).
  Article CAS Google Scholar
• Anand, K. et al. Coronavirus main protease (3Clpro) structure: basis for design of antiviral drugs. Science 300, 1763–1767 (2003).
  Article CAS PubMed Google Scholar
• Ivanov, K.A. et al. Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase. J. Virol. 78, 5619–5632 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• He, M.L. et al. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA 290, 2665–2666 (2003).
  Article CAS PubMed Google Scholar
• Wang, Z. et al. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNA in mammalian cells. J. Virol. 78, 7523–7527 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Y. et al. Silencing SARS CoV spike protein expression in cultured cells by RNA interference. FEBS Lett. 560, 141–146 (2004).
  Article CAS PubMed Google Scholar
• Kao, R.Y. et al. Identification of novel small molecule inhibitors of severe acute respiratory syndrome associated coronavirus by chemical genetics. Chem. Biol. 11, 1293–1299 (2004).
  Article CAS PubMed Google Scholar
• Lu, L. et al. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J. Clin. Microbiol. 42, 1570–1576 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, H. et al. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike protein capable of inducing neutralizing antibodies. J. Virol. 78, 6938–6945 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y.D. et al. T cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. J. Virol. 78, 5612–5618 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Nie, Y. et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J. Infect. Dis. 190, 1119–1126 (2004).
  Article PubMed Google Scholar
• Yang, Z.Y. et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428, 561–564 (2004).
  Article CAS PubMed Google Scholar
• Kim, T.W. et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J. Virol. 78, 4638–4645 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zeng, F. et al. Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. Biochem. Biophys. Res. Commun. 315, 1134–1139 (2004).
  Article CAS PubMed Google Scholar
• Zhu, M.S. et al. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett. 92, 237–243 (2004).
  Article CAS PubMed Google Scholar
• Gao, W. et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 362, 1895–1896 (2003).
  Article CAS PubMed Google Scholar
• Bisht, H. et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci. USA 101, 6641–6646 (2004).
  Article CAS PubMed Google Scholar
• Takasuka, N. et al. A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. Int. Immunol. 16, 1423–1430 (2004).
  Article CAS PubMed Google Scholar
• Tang, L. et al. Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice. DNA Cell Biol. 23, 391–394 (2004).
  Article CAS PubMed Google Scholar
• Cavanagh, D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 32, 567–582 (2003).
  Article CAS PubMed Google Scholar
• Olsen, C.W. A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet. Microbiol. 36, 1–37 (1993).
  Article CAS PubMed Google Scholar
• Sui, J. et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAB to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. USA 101, 2536–2641 (2004).
  Article CAS PubMed Google Scholar
• Ter Muelen, J. et al. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363, 2139–2141 (2004).
  Article CAS Google Scholar
• Traggian, E. et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10, 871–875 (2004).
  Article CAS Google Scholar
• Soo, Y.O.Y. et al. Retrospective comparison of convalescent plasma with continuing high dose methyl prednisolone treatment in SARS patients. Clin. Microbiol. Infect. 10, 657–658 (2004)
  Article Google Scholar
• Smolinski, M.S., Hamburg, M.A. & Lederberg, J. (eds). Microbial Threats to Health: Emergence, Detection and Response (National Academy Press, Washington, DC, 2003).
  Google Scholar
• Li, K.S. et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430, 209–213 (2004).
  Article CAS PubMed Google Scholar
• Mackenzie, J.S., Field, H.F. & Guyatt, K.J. Managing emerging diseases borne by fruit bats (flying foxes), with particular reference to henipaviruses and Australian bat lyssavirus. J. Appl. Microbiol. 94 Suppl, 59S–69S (2003).
  Article PubMed Google Scholar
• Poon, L.L.M. et al. Identification of a novel coronavirus in bats. J. Virol. (in the press).
• Singer, P.A. et al. Ethics and SARS: Lessons from Toronto. BMJ 327, 1342–1344 (2003).
  Article PubMed PubMed Central Google Scholar
• O'Neill, O. Informed consent and public health. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359, 1133–1136 (2004)
  Article PubMed PubMed Central Google Scholar
• World Health Organization. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 361, 1730–1733 (2003).
• Fidler, D.P. Germs, governance, and global public health in the wake of SARS. J. Clin. Invest. 113, 799–804 (2004).
  Article CAS PubMed PubMed Central Google Scholar